国家卫健委紧急叫停两项手术

Core Viewpoint - The National Health Commission has issued notifications prohibiting the use of "jejunum-ileum anastomosis" for the treatment of type 2 diabetes and "cervical deep lymphatic vessel/lymph node-venous anastomosis" for Alzheimer's disease, citing lack of safety and efficacy evidence [2][6]. Group 1: Jejunum-Ileum Anastomosis - Jejunum-ileum anastomosis is a surgical procedure that connects the jejunum and ileum, primarily used for bowel obstruction, tumor resection reconstruction, or congenital malformation repair [3]. - The assessment concluded that the safety and efficacy of jejunum-ileum anastomosis for diabetes treatment are uncertain, with potential severe complications such as liver failure and malnutrition [4]. - Local health authorities are required to ensure that medical institutions cease the use of this technique for diabetes treatment and enhance regulatory oversight [5]. Group 2: Cervical Deep Lymphatic Vessel/Venous Anastomosis - Cervical deep lymphatic vessel/lymph node-venous anastomosis is a microsurgical technique that connects lymphatic vessels or nodes to nearby veins, mainly used for treating persistent lymphedema [7]. - The evaluation indicated that this technique is still in the early exploratory stage of clinical research, lacking direct evidence for safety, efficacy, and economic viability [8]. - Provincial health authorities must oversee the cessation of this technique's application for Alzheimer's treatment and guide qualified medical institutions in conducting clinical research in a scientific and regulated manner [9].